Congratulations to the researchers who successfully sought grants in the ACT Health and Medical Research Program funding round for 2004/5. Details of their projects are listed below.
Applications were assessed by the ACT Health and Medical Research Council. Professor Scott Henderson, Chair of the Council, commented on the high standard and diversity of the projects.
The 2005 call for applications received 19 applications. Applications were assessed by the ACT Health and Medical Research Council. Professor Scott Henderson, Chair of the Council, commented on the high standard and diversity of the projects.
Funding was awarded to the following applicants in the 2005 funding round.
|Professor David Elwood & Ms Joanna HoltWomen's Hospitals Australasia Inc.||A Prospective Cohort Study of Morbidity Following Significant Postpartum Haemorrhage (PPH)This project aims to investigate the impact of PPH on short and medium term morbidity using standard instruments to assess various aspects of maternal health.||$50,000|
|Professor Roger Dean & Dr Ruth FoxwellUniversity of Canberra||DOPA as a Potential Therapeutic for Diseases of Oxidative StressTo test whether sacrificial and enzymatic antioxidants are under control of DOPA in human cells and to determine the range of proteins which are regulated by DOPA.||$50,000|
|Dr Rosemary MartinSchool of Biochemistry and Molecular Biology (BaMBi)ANU||Diagnostic Proteomic Approach to Identification of Hypoxic-Ischaemic Neonatal Brain Injury in RatsThis study will use a proteomic approach to examine changes in protein expression with time after an hypoxic insult in an animal model of neonatal asphyxia.||$49,156|
|Dr Christine KilhamUniversity of Canberra||A Collaborative Therapeutic Intervention for Children with AutismThis fellowship will assist services to better and more consistently meet the needs of young children with autism and their families.||$28,476|
|Dr Pam MegawUniversity of Canberra||Molecular Changes in the Retina During the Development of MyopiaThe aim of this project is to characterise the molecular changes in the eye during the development of myopia as the basis for defining the mechanism of action of atropine, and for the development of alternative therapies.||$24,000|